The world's scientific and social network for malaria professionals
9430 malaria professionals are enjoying the free benefits of MalariaWorld today

Research: Distribution of pfmdr1 and pfcrt chloroquine drug resistance alleles in north-western Nigeria

August 25, 2017 - 07:35 -- MalariaWorld Journal
Author(s): 
Ruqayyah H. Muhammad, Ishaya H. Nock, Iliya S. Ndams, Jonathan B. George, Yusuf Deeni
Reference: 
MWJ2017,8,15
Article type: 
Research
Abstract: 
 
In Nigeria, decline in the sensitivity of Plasmodium falciparum to Artemisinin Combination Therapy (ACT) has prompted the unofficial use of chloroquine (CQ) for self-medication. This study was designed to determine the prevalence and distribution of CQ resistant/susceptible alleles of CQ resistance transporter (Pfcrt) and P. falciparum multidrug resistance gene 1 (Pfmdr1) in view of the possible re-introduction of CQ for malaria treatment. Four hundred and sixty six (466) P. falciparum positive samples were randomly collected from five states of northwest Nigeria. Drug susceptible alleles (N86) were most prevalent in the study population (47.9%; 223/466), followed by the drug resistance alleles 86Y (28.3%; 132/466), followed by the drug susceptible alleles K76 (17.4%; 81/466), the resistant alleles 76T (12.4%; 58/466) and finally the mixed infection mutation K76T (3.6%; 17/466). Differences between the distributions of the Pfmdr1and Pfcrt alleles were significant (P<0.05). There were significant differences (P<0.05) between N86 and 86Y alleles, but no significant differences between K76 and 76T alleles, including the prevalence of the various alleles across the different age groups. The results of this study suggest the possibility of (re)introducing CQ for malaria treatment in north-western Nigeria and provide insight in the genetic background of P. falciparum in the study area.

 

AttachmentSize
PDF icon MWJ2017_8_15.pdf742.32 KB
PDF icon Supplementary file 1.pdf78.94 KB